Humanigen Inc (fka HGENQ)

[eom7]

HGEN Presentation tomorrow:
Humanigen, Inc., (Nasdaq: HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm' with its lead drug candidate lenzilumab(TM), today announced that the Company's management will present or participate in panel discussions at the following upcoming virtual investor conferences:



This seems very last second. Do we finally have something to say? I am guessing we see a PR tomorrow morning!